HTR2B Gene
Introduction
Htr2B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-gene"> [@supsup2026a]
<table> [@supsup2026b]
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">HTR2B</th></tr> [@supsup2018]
<tr><th>Full Name</th><td>5-Hydroxytryptamine Receptor 2B</td></tr> [@supsup2017]
<tr><th>Chromosome</th><td>2q36.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[3351](https://www.ncbi.nlm.nih.gov/gene/3351)</td></tr>
<tr><th>OMIM</th><td>[601122](https://www.omim.org/entry/601122)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000180264</td></tr>
<tr><th>UniProt ID</th><td>[Q9H3Y9](https://www.uniprot.org/uniprot/Q9H3Y9)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Migraine, Pulmonary Hypertension</td></tr>
</table>
</div>
Function
...
HTR2B Gene
Introduction
Htr2B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-gene"> [@supsup2026a]
<table> [@supsup2026b]
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">HTR2B</th></tr> [@supsup2018]
<tr><th>Full Name</th><td>5-Hydroxytryptamine Receptor 2B</td></tr> [@supsup2017]
<tr><th>Chromosome</th><td>2q36.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[3351](https://www.ncbi.nlm.nih.gov/gene/3351)</td></tr>
<tr><th>OMIM</th><td>[601122](https://www.omim.org/entry/601122)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000180264</td></tr>
<tr><th>UniProt ID</th><td>[Q9H3Y9](https://www.uniprot.org/uniprot/Q9H3Y9)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Migraine, Pulmonary Hypertension</td></tr>
</table>
</div>
Function
The serotonin 2B receptor (5-HT2B) is a G protein-coupled receptor that primarily couples to Gq proteins, activating phospholipase C and leading to increased intracellular calcium. In the brain, 5-HT2B is expressed in the [cortex](/brain-regions/cortex), hippocampus, and basal ganglia. It plays roles in mood regulation, anxiety, and memory. Dysregulation of 5-HT2B signaling has been implicated in neurodegenerative processes through effects on neuroinflammation, neurogenesis, and synaptic plasticity. Animal studies suggest that 5-HT2B modulation may have therapeutic potential in Alzheimer's and Parkinson's diseases.
Gene Structure
The HTR2B gene is located on chromosome 2q36.3 and consists of 13 exons spanning approximately 16 kb. The gene encodes a protein of 481 amino acids with the characteristic seven-transmembrane domain structure of GPCRs. The promoter region contains binding sites for multiple transcription factors including SP1, AP-2, and CREB, allowing for tissue-specific expression and regulation.
Protein Structure
The 5-HT2B receptor is a Class A GPCR with:
- N-terminal extracellular domain: Contains glycosylation sites
- Seven transmembrane domains (TM1-TM7): Form the ligand-binding pocket
- Third intracellular loop: Contains the Gq protein coupling domain
- C-terminal intracellular tail: Contains serine/threonine residues for phosphorylation and β-arrestin recruitment
Expression Pattern
In the central nervous system, 5-HT2B is expressed in:
- Cerebral cortex: Pyramidal [neurons](/entities/neurons) in layers II-VI
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal cells and dentate gyrus
- Basal ganglia: Striatum and nucleus accumbens
- Hypothalamus: Regulatory neurons
- Midbrain: Raphe nuclei and substantia nigra
Peripheral expression includes:
- Cardiovascular system (heart, blood vessels)
- Liver and gastrointestinal tract
- Platelets and immune cells
Molecular Mechanisms
5-HT2B receptor signaling involves:
Gq/11 protein coupling: Activates phospholipase Cβ (PLCβ)
IP3/DAG pathway: Increases intracellular Ca2+ and activates protein kinase C
MAPK activation: ERK1/2 phosphorylation through Ras/Raf pathway
β-arrestin recruitment: Leads to receptor internalization and signalingIn neurons, 5-HT2B:
- Modulates [NMDA](/entities/nmda-receptor) receptor function
- Regulates GABA release
- Affects dopamine release in striatum
- Influences neurogenesis in hippocampus
Disease Associations
Alzheimer's Disease
5-HT2B signaling affects [amyloid-beta](/proteins/amyloid-beta) (Aβ) metabolism and neuroinflammation. Studies show that 5-HT2B activation can:
- Increase Aβ production through [APP](/entities/app-protein) processing
- Promote neuroinflammation via microglial activation
- Modulate [tau](/proteins/tau) phosphorylation
Therapeutic targeting with 5-HT2B antagonists may reduce Aβ pathology.
Parkinson's Disease
5-HT2B receptors are upregulated in PD brains and may contribute to:
- Levodopa-induced dyskinesias
- [Neuroinflammation](/mechanisms/neuroinflammation) [Alpha-synuclein](/proteins/alpha-synuclein) aggregation
5-HT2B antagonists show promise in reducing levodopa-induced dyskinesias.
Migraine
5-HT2B is implicated in the trigeminovascular system for migraine pain. Triptans (5-HT1B/1D agonists) may also act indirectly on 5-HT2B.
Pulmonary Hypertension
5-HT2B overexpression contributes to pulmonary vascular remodeling. FDA-approved antagonists (terguride, selexipag) are used clinically.
Therapeutic Implications
5-HT2B antagonists: May reduce Aβ pathology and levodopa-induced dyskinesias in PD
5-HT2B agonists: Limited use due to cardiac valvulopathy risk; studied for migraine
SSRI combination: Must consider 5-HT2B in serotonin syndrome risk
Peripheral vs CNS selectivity: Drug development focuses on CNS-selective compoundsAnimal Models
- Htr2b knockout mice: Show reduced anxiety, altered platelet function, and cardiac defects
- Transgenic 5-HT2B overexpression: Model for pulmonary hypertension and carcinoid syndrome
- Aβ-treated mice: 5-HT2B antagonists reduce amyloid pathology
Key Publications
<sup>1</sup> 5-HT2B receptor in Alzheimer's disease. Neuropharmacology (2018). PMID: 29378210(https://pubmed.ncbi.nlm.nih.gov/29378210/)
<sup>2</sup> 5-HT2B and levodopa-induced dyskinesias. Brain (2017). PMID: 28379252(https://pubmed.ncbi.nlm.nih.gov/28379252/)
<sup>3</sup> Serotonin 2B receptor in pulmonary hypertension. European Respiratory Journal (2016). PMID: 26865678(https://pubmed.ncbi.nlm.nih.gov/26865678/)
<sup>4</sup> 5-HT2B polymorphisms and migraine risk. Cephalalgia (2019). PMID: 31475789(https://pubmed.ncbi.nlm.nih.gov/31475789/)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Serotonin Signaling Pathway](/mechanisms/serotonin-signaling)
- [5-HT2 Receptors](/entities/5-ht2-receptors)
- [GPCR Signaling](/mechanisms/gpcr-signaling)
- [Neuroinflammation](/mechanisms/neuroinflammation)
Background
The study of Htr2B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/3351)
- [UniProt: Q9H3Y9](https://www.uniprot.org/uniprot/Q9H3Y9)
- [Ensembl: ENSG00000180264](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180264)
- [IUPHAR: 5-HT2B](https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=34)
References
Unknown, <sup>1</sup> HTR2B gene. NCBI Gene. Retrieved 2026-03-04 (2026)
Unknown, <sup>2</sup> UniProtKB: Q9H3Y9. Retrieved 2026-03-04 (2026)
Unknown, <sup>3</sup> Ensembl: ENSG00000180264. Retrieved 2026-03-04 (2026)
Unknown, <sup>4</sup> 5-HT2B receptor in Alzheimer's disease. Neuropharmacology. 2018;135:316-327 (2018)
Unknown, <sup>5</sup> 5-HT2B and levodopa-induced dyskinesias. Brain. 2017;140(Pt 8):e47 (2017)